University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3) : a multicentre, randomised, double-blind, placebo-controlled trial

dc.contributor.authorGEM3 collaborative
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.date.accessioned2023-03-20T11:36:01Z
dc.date.available2023-03-20T11:36:01Z
dc.date.issued2023-02-25
dc.descriptionAWH has received funding from NIHR HTA and UK Research and Innovation. WCD is immediate past chair of the Society for Reproduction and Fertility. BWM is supported by an the National Health and Medical Research Council Investigator grant (GNT1176437). AC is immediate past member of the NIHR Efficacy and Mechanism Evaluation Programme Funding Committee. JPD is a member of the NIHR Clinical Trials Unit Standing Advisory Committee.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent939798
dc.identifier229414861
dc.identifier1179e079-9833-45af-be11-7772b43d19c8
dc.identifier36738759
dc.identifier85148667333
dc.identifier.citationGEM3 collaborative 2023, 'Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3) : a multicentre, randomised, double-blind, placebo-controlled trial', Lancet (London, England), vol. 401, no. 01377, pp. 655-663. https://doi.org/10.1016/S0140-6736(22)02478-3en
dc.identifier.doi10.1016/S0140-6736(22)02478-3
dc.identifier.iss01377en
dc.identifier.issn0140-6736
dc.identifier.urihttps://hdl.handle.net/2164/20316
dc.identifier.vol401en
dc.language.isoeng
dc.relation.ispartofLancet (London, England)en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectMedical Research Council (MRC)en
dc.subjectGNT1176437en
dc.subjectUK Research and Innovation (UKRI)en
dc.subject.lccRen
dc.titleCombination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3) : a multicentre, randomised, double-blind, placebo-controlled trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Horne_etal_TL_Combination_Of_Gefitinib_VoR.pdf
Size:
917.77 KB
Format:
Adobe Portable Document Format

Collections